UPDATE: Turing Pharma CEO Shkreli Resigns; Co. Remains Committed to Affordable Daraprim, Vecamyl Access
Go back to UPDATE: Turing Pharma CEO Shkreli Resigns; Co. Remains Committed to Affordable Daraprim, Vecamyl Access| KALOBIOS PHARM (AMEX: KBIO) | Delayed: 2.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.19 | 52 Week High | $45.82 | |||
| Open | $0.00 | 52 Week Low | $0.90 | |||
| Day High | $2.19 | P/E | N/A | |||
| Day Low | $2.19 | EPS | $-11.85 | |||
| Volume | 1,075,000 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.61 +0.17 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.44 | 52 Week High | $3.48 | |||
| Open | $58.27 | 52 Week Low | $0.80 | |||
| Day High | $59.03 | P/E | N/A | |||
| Day Low | $57.86 | EPS | $-1.54 | |||
| Volume | 806,788 | |||||
